UP!

News

Celator Pharmaceuticals, Inc. (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2016 2016-11-14 Future report Set alerts
Q2 2016 2016-08-11 Future report Set alerts
Q1 2016 2016-05-10 -0.16 -0.16
Q4 2015 2016-03-21 -0.13 -0.13
Q3 2015 2015-11-12 -0.15 -0.15
Q2 2015 2015-08-11 -0.15 -0.15
Q1 2015 2015-05-07 -0.14 -0.14
Q4 2014 2015-03-17 -0.07 -0.07
Q3 2014 2014-11-13 -0.21 -0.21
Q2 2014 2014-08-07 -0.18 -0.18

Ratings

2016-06-01 Downgrade Janney Montgomery Scott Buy to Neutral
2016-06-01 Downgrade Stifel Nicolaus Buy to Hold
2016-05-31 Downgrade Needham & Company LLC Buy to Hold
2016-05-31 Downgrade Roth Capital Buy to Neutral $30.25 to $26.00
2016-05-19 Reiterated Rating Roth Capital Buy $22.00 to $26.00
2016-04-22 Initiated Coverage Stifel Nicolaus Buy $23.00
2016-04-12 Reiterated Rating Roth Capital Buy $22.00
2016-04-12 Initiated Coverage Needham & Company LLC Buy $24.00
2016-03-22 Reiterated Rating Roth Capital Buy $22.00
2016-03-15 Boost Price Target Roth Capital Buy $18.00 to $22.00
2016-03-15 Boost Price Target HC Wainwright Buy $20.00
2016-03-15 Initiated Coverage Janney Montgomery Scott Buy $13.00
2015-10-30 Reiterated Rating FBR & Co. Outperform
2015-10-30 Reiterated Rating FBR & Co Outperform
2015-09-25 Reiterated Rating Roth Capital Buy
2015-08-12 Reiterated Rating MLV & Co. Buy $6.00
2015-07-27 Boost Price Target Roth Capital Buy $15.00 to $18.00
2015-07-17 Reiterated Rating Roth Capital Buy $15.00
2015-06-26 Initiated Coverage MLV & Co. Buy
2015-06-26 Reiterated Rating Roth Capital Buy $15.00
2015-06-26 Reiterated Rating HC Wainwright Buy
2015-06-19 Initiated Coverage MLV & Co. Buy $6.00
2015-06-08 Reiterated Rating Roth Capital Buy $15.00
2014-09-05 Initiated Coverage HC Wainwright Buy $7.00
2016-06-01 Downgrade Janney Montgomery Scott Buy to Neutral
2016-06-01 Downgrade Stifel Nicolaus Buy to Hold
2016-05-31 Downgrade Needham & Company LLC Buy to Hold
2016-05-31 Downgrade Roth Capital Buy to Neutral $30.25 to $26.00
2016-05-19 Reiterated Rating Roth Capital Buy $22.00 to $26.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In CPXX 1 funds of 2183 total. Show all

Fund name Ticker shares
RUSSELL FRANK CO/ 0.12M

Major Shareholders

Name Relationship Total Shares Holding stocks
VENTURES WEST CAPITAL LTD 8.23%  (2146372) CPXX /
QUAKER BIO VENTURES LP 2.26%  (590427) CPXX / OCRX / RGDO /

Comments